Component information
No US or EU label exists for this exact combination, so information is shown for each component.
- allantoin no separate page
- allium cepa l extract no separate page
Use: Anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures. US FDA label
Kidney dosing: Heparin (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- Full-dose IV: 5,000 units bolus, then 20,000 to 40,000 units/24 hours by infusion, adjusted to coagulation tests. Prophylaxis: 5,000 units SC 2 hours before surgery, then every 8 to 12 hours (label). No kidney dose adjustment in the label; dose by indication and coagulation tests (aPTT or anti-Xa for full-dose therapy).
- CrCl 30–59 mL/min
- No kidney dose adjustment in the label; dose by indication and coagulation tests (aPTT or anti-Xa for full-dose therapy).
- CrCl 15–29 mL/min
- No kidney dose adjustment in the label; dose by indication and coagulation tests (aPTT or anti-Xa for full-dose therapy). Not renally cleared: the usual parenteral anticoagulant when CrCl is under 30 or on dialysis, where low-molecular-weight heparins accumulate (see enoxaparin).
- CrCl <15 mL/min (not on dialysis)
- No kidney dose adjustment in the label; dose by indication and coagulation tests (aPTT or anti-Xa for full-dose therapy). Not renally cleared: the usual parenteral anticoagulant when CrCl is under 30 or on dialysis, where low-molecular-weight heparins accumulate (see enoxaparin).
- Hemodialysis (intermittent)
- Circuit anticoagulation: follow the equipment maker's directions; if none, 25 to 30 units/kg, then 1,500 to 2,000 units/hour (label 2.9). Systemic doses: no kidney adjustment. Not renally cleared: the usual parenteral anticoagulant when CrCl is under 30 or on dialysis, where low-molecular-weight heparins accumulate (see enoxaparin).
- Peritoneal dialysis
- No kidney dose adjustment in the label; dose by indication and coagulation tests (aPTT or anti-Xa for full-dose therapy).
- CRRT
- No CRRT-specific dose in the label (2.9 covers extracorporeal dialysis generally: follow the equipment maker's directions). Use the unit's CRRT anticoagulation protocol; specialist input.
- Dialyzable? Not stated in label.
- Monitoring aPTT (or anti-Xa) for full-dose therapy; platelet count (heparin-induced thrombocytopenia: stop if below 100,000/mm3 or new thrombosis); hemoglobin and signs of bleeding. Potassium in CKD: the label lists suppression of aldosterone synthesis (link to hyperkalemia is clinical extrapolation).
From the Heparin monograph (renalcarematters.com, reviewed).
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Gel: 500 IU/100 mg/1 g
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Allantoin + Allium cepa l extract + Heparin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
ClindermHeparin + Allantoin + Allium cepa L. (Onion) extract | 500 IU/ 100 mg/ 1 g GelAluminum collapsible tube x 10 g (Box of 1's) | Rx | Kolmar Pharma Co., Ltd.Republic of Korea | Ambicare Pharmaceuticals Inc. | DRP-9554 | Apr 13, 2030 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .